Editorial: Facing the Upcoming of Multidrug-Resistant and Extensively Drug-Resistant Bacteria: Novel Antimicrobial Therapies (NATs).
作者信息
León-Buitimea Angel, Morones-Ramírez Jose Ruben, Yang Jason H, Peña-Miller Rafael
机构信息
Facultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, UANL, San Nicolás de los Garza, Mexico.
Centro de Investigación en Biotecnología y Nanotecnología, Facultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, Parque de Investigación e Innovación Tecnológica, Apodaca, Mexico.
出版信息
Front Bioeng Biotechnol. 2021 Feb 23;9:636278. doi: 10.3389/fbioe.2021.636278. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: Facing the Upcoming of Multidrug-Resistant and Extensively Drug-Resistant Bacteria: Novel Antimicrobial Therapies (NATs).社论：直面多重耐药菌和广泛耐药菌的出现：新型抗菌疗法（NATs）
Front Bioeng Biotechnol. 2021 Feb 23;9:636278. doi: 10.3389/fbioe.2021.636278. eCollection 2021.
2
The Demand for New Antibiotics: Antimicrobial Peptides, Nanoparticles, and Combinatorial Therapies as Future Strategies in Antibacterial Agent Design.新型抗生素的需求：抗菌肽、纳米颗粒及联合疗法作为抗菌药物设计的未来策略
Front Microbiol. 2020 Jul 24;11:1669. doi: 10.3389/fmicb.2020.01669. eCollection 2020.
3
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.一种抗菌肽对革兰氏阴性细菌病原体的多重耐药和广泛耐药菌株的协同活性谱。
J Pept Sci. 2017 Apr;23(4):329-333. doi: 10.1002/psc.2978. Epub 2017 Feb 8.
4
Novel antimicrobial peptide CPF-C1 analogs with superior stabilities and activities against multidrug-resistant bacteria.具有卓越稳定性且对多重耐药菌有活性的新型抗菌肽CPF-C1类似物。
Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988. Epub 2017 May 14.
5
Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.Romo1 衍生抗菌肽是一种新型抗微生物剂，可用于治疗脓毒症小鼠模型中的多重耐药菌。
mBio. 2020 Apr 14;11(2):e03258-19. doi: 10.1128/mBio.03258-19.
6
Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria.银纳米粒子：对抗多重耐药菌的强效纳米武器。
J Appl Microbiol. 2012 May;112(5):841-52. doi: 10.1111/j.1365-2672.2012.05253.x. Epub 2012 Mar 28.
7
Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.应对多重耐药菌的威胁及未来问题
Curr Top Microbiol Immunol. 2016;398:3-33. doi: 10.1007/82_2016_492.
8
Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.应对抗生素耐药性：将纳米颗粒与抗生素和其他抗菌剂结合使用。
Expert Rev Anti Infect Ther. 2011 Nov;9(11):1035-52. doi: 10.1586/eri.11.121.
9
Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria.新型超短抗菌肽纳米颗粒的研发，其对多重耐药菌具有强大的抗菌和抗生物膜活性。
Drug Des Devel Ther. 2017 Nov 3;11:3159-3170. doi: 10.2147/DDDT.S147450. eCollection 2017.
10
Antimicrobial activities and membrane-active mechanism of CPF-C1 against multidrug-resistant bacteria, a novel antimicrobial peptide derived from skin secretions of the tetraploid frog Xenopus clivii.CPF-C1（一种源自四倍体青蛙克氏爪蟾皮肤分泌物的新型抗菌肽）对多重耐药菌的抗菌活性及膜作用机制
J Pept Sci. 2014 Nov;20(11):876-84. doi: 10.1002/psc.2679. Epub 2014 Aug 6.
引用本文的文献
1
Biomimetic Metal-Organic Framework Gated Nanoplatform for Sonodynamic Therapy against Extensively Drug Resistant Bacterial Lung Infection.仿生金属有机框架栅纳米平台用于声动力学治疗广泛耐药菌肺部感染。
Adv Sci (Weinh). 2024 Sep;11(33):e2402473. doi: 10.1002/advs.202402473. Epub 2024 Jul 4.
2
Designing of fragment based inhibitors with improved activity against AmpC β-lactamase compared to the conventional antibiotics.与传统抗生素相比，设计对AmpC β-内酰胺酶具有更高活性的基于片段的抑制剂。
Saudi J Biol Sci. 2024 Jan;31(1):103884. doi: 10.1016/j.sjbs.2023.103884. Epub 2023 Nov 25.
3
Antibacterial and Antibiofilm Potency of Menadione Against Multidrug-Resistant S. aureus.亚甲二氢叶酸还原酶抑制剂对耐多药金黄色葡萄球菌的抗菌和抗生物膜活性。
Curr Microbiol. 2022 Aug 8;79(9):282. doi: 10.1007/s00284-022-02975-6.
4
Spectral analysis and antibacterial potential of bioactive principles of J. Agardh from Red sea of Jazan origin.来自吉赞红海的红藻琼枝生物活性成分的光谱分析及抗菌潜力
Saudi J Biol Sci. 2021 Oct;28(10):5745-5753. doi: 10.1016/j.sjbs.2021.06.017. Epub 2021 Jun 11.
本文引用的文献
1
Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.对抗ESKAPE病原体以防治医院感染的注意事项及警示
Adv Sci (Weinh). 2019 Dec 5;7(1):1901872. doi: 10.1002/advs.201901872. eCollection 2020 Jan.
2
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.抗菌药物耐药时代对抗ESKAPE病原体的新兴策略：综述
Front Microbiol. 2019 Apr 1;10:539. doi: 10.3389/fmicb.2019.00539. eCollection 2019.
3
The negative impact of antibiotic resistance.抗生素耐药性的负面影响。
Clin Microbiol Infect. 2016 May;22(5):416-22. doi: 10.1016/j.cmi.2015.12.002. Epub 2015 Dec 17.
4
Antimicrobial resistance: a global multifaceted phenomenon.抗菌药物耐药性：一种全球多层面现象。
Pathog Glob Health. 2015;109(7):309-18. doi: 10.1179/2047773215Y.0000000030. Epub 2015 Sep 7.
5
The antibiotic resistance crisis: part 1: causes and threats.抗生素耐药性危机：第一部分：成因与威胁。
P T. 2015 Apr;40(4):277-83.
6
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.耐多药、广泛耐药和全耐药细菌：获得性耐药的国际专家临时标准定义建议
Clin Microbiol Infect. 2012 Mar;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x. Epub 2011 Jul 27.
Zotero 插件